{
    "2018-11-02": [
        [
            {
                "time": "2018-11-02",
                "original_text": "TESARO (TSRO) Q3 Earnings Beat, Revenues Miss, Shares Up",
                "features": {
                    "keywords": [
                        "Earnings Beat",
                        "Revenues Miss",
                        "Shares Up"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-02",
                "original_text": "AbbVie sees hit to Humira sales from European competition",
                "features": {
                    "keywords": [
                        "Humira",
                        "European competition",
                        "sales hit"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-11-02",
                "original_text": "AbbVie (ABBV) Q3 Earnings Beat Estimates, 2018 EPS View Up",
                "features": {
                    "keywords": [
                        "Earnings Beat",
                        "EPS View Up"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-02",
                "original_text": "MARKETS: Now Facebook, J&J, Pfizer and Merck are dragging down the market, while Exxon and Chevron are bright spots",
                "features": {
                    "keywords": [
                        "Facebook",
                        "J&J",
                        "Pfizer",
                        "Merck",
                        "dragging down",
                        "Exxon",
                        "Chevron",
                        "bright spots"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology",
                        "healthcare",
                        "energy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-11-02",
                "original_text": "VIVUS (VVUS) Q3 Loss Narrower Than Expected, Revenues Up Y/Y",
                "features": {
                    "keywords": [
                        "Loss Narrower",
                        "Revenues Up Y/Y"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-02",
                "original_text": "Geron's Horrible Year Is a Great Reminder to Investors",
                "features": {
                    "keywords": [
                        "Horrible Year",
                        "Reminder",
                        "Investors"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-11-02",
                "original_text": "IWD, JPM, XOM, JNJ: ETF Inflow Alert",
                "features": {
                    "keywords": [
                        "ETF Inflow",
                        "IWD",
                        "JPM",
                        "XOM",
                        "JNJ"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "financials",
                        "energy",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-02",
                "original_text": "The Kiplinger Dividend 15: Our Favorite Dividend-Paying Stocks",
                "features": {
                    "keywords": [
                        "Dividend",
                        "Favorite Stocks"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "dividend stocks"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-11-02",
                "original_text": "AbbVie Earnings, Revenue beat in Q3",
                "features": {
                    "keywords": [
                        "Earnings Beat",
                        "Revenue Beat"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-02",
                "original_text": "Geron's (GERN) Q3 Earnings Beat, Revenues Miss, Shares Down",
                "features": {
                    "keywords": [
                        "Earnings Beat",
                        "Revenues Miss",
                        "Shares Down"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-11-02",
                "original_text": "Health Care Sector Update for 11/02/2018: PACB, ILMN, EXEL, PBYI, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Health Care Sector",
                        "Update",
                        "PACB",
                        "ILMN",
                        "EXEL",
                        "PBYI",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "MRK",
                        "AMGN"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-02",
                "original_text": "See what the IHS Markit Score report has to say about Johnson & Johnson.",
                "features": {
                    "keywords": [
                        "IHS Markit Score",
                        "Johnson & Johnson"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-02",
                "original_text": "Scary Markets, Frightening Stocks, and How to Keep From Panicking",
                "features": {
                    "keywords": [
                        "Scary Markets",
                        "Frightening Stocks",
                        "Panicking"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}